(6R)-6-(Hydroxymethyl)morpholin-3-one, 98+%, 250mg

5-Azacytidine, 97.0%, 5g

4-(5-Chloro-thiophen-2-yl)thiazol-2-ylamine, 95.0%, 1g

1-Iodo-2-methoxy-3,5-bis(trifluoromethyl)benzene, 98%, 250mg

4-Ethoxy-3-fluorobenzeneboronic acid, 97.0%, 10g

4-(2-Aminoethyl)morpholine>98.0%(GC)(T)500g

METHYL 4-CYANO-2,3-DIFLUOROBENZOATE, 95.0%, 250mg

Microliter syringe GASTIGHT® series 1700 Point type 2, 25 µl, 1702 RN, 1 piece

1-(Piperidin-4-ylmethyl)-2,5-dihydro-1h-pyrrole-2,5-dione hydrochloride, 98%, 100mg

3-Amino-2-naphthoic acid, 97.0%, 5g

4-Methoxy-N-methyl-2-nitroaniline, 95.0%, 5g

4-Bromo-3-fluoro-2-methylbenzonitrile, 98.0%, 100mg

4-Chloro-1-methylpiperidine>98.0%(GC)(T)5g